NCT00282256View on ClinicalTrials.gov

A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Liver Transplantation
Interventions
DRUG

tacrolimus modified release (MR)

Oral

DRUG

tacrolimus

Oral

Trial Locations (5)

10029

New York

30322

Atlanta

46202

Indianapolis

53792

Madison

70433

New Orleans

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY